Propyphenazone: Difference between revisions
m Protected "Propyphenazone": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
Rabin Bista (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{drugbox | {{drugbox | ||
| IUPAC_name = ''1,5-dimethyl-2-phenyl-4-propan-2-ylpyrazol-3-one'' | | IUPAC_name = ''1,5-dimethyl-2-phenyl-4-propan-2-ylpyrazol-3-one'' | ||
| image = | | image = Propylphenazone Wiki Str.png | ||
| width = 180 | | width = 180 | ||
| CAS_number = 479-92-5 | | CAS_number = 479-92-5 | ||
| Line 20: | Line 20: | ||
| routes_of_administration = Oral | | routes_of_administration = Oral | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
== Overview == | |||
'''Propyphenazone''' or '''Isopropylantipyrine''' (C<sub>14</sub>H<sub>18</sub>N<sub>2</sub>O, 1,2-dihydro-1,5-dimethyl-4-(isopropyl)-2-phenyl-pyrazol-3-one) is a metabolite of [[phenacetin]] with similar analgesic and antipyretic effects. | '''Propyphenazone''' or '''Isopropylantipyrine''' (C<sub>14</sub>H<sub>18</sub>N<sub>2</sub>O, 1,2-dihydro-1,5-dimethyl-4-(isopropyl)-2-phenyl-pyrazol-3-one) is a metabolite of [[phenacetin]] with similar analgesic and antipyretic effects. | ||
| Line 31: | Line 35: | ||
[[de:Propyphenazon]] | [[de:Propyphenazon]] | ||
[[Category:Drug]] | |||
[[Category:Analgesics]] | [[Category:Analgesics]] | ||
[[Category:Antipyretics]] | [[Category:Antipyretics]] | ||
[[Category:Pyrazolones]] | [[Category:Pyrazolones]] | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Latest revision as of 13:45, 9 April 2015
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C14H18N2O |
| Molar mass | 230.306 g/mol |
|
WikiDoc Resources for Propyphenazone |
|
Articles |
|---|
|
Most recent articles on Propyphenazone Most cited articles on Propyphenazone |
|
Media |
|
Powerpoint slides on Propyphenazone |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Propyphenazone at Clinical Trials.gov Trial results on Propyphenazone Clinical Trials on Propyphenazone at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Propyphenazone NICE Guidance on Propyphenazone
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Propyphenazone Discussion groups on Propyphenazone Patient Handouts on Propyphenazone Directions to Hospitals Treating Propyphenazone Risk calculators and risk factors for Propyphenazone
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Propyphenazone |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Propyphenazone or Isopropylantipyrine (C14H18N2O, 1,2-dihydro-1,5-dimethyl-4-(isopropyl)-2-phenyl-pyrazol-3-one) is a metabolite of phenacetin with similar analgesic and antipyretic effects.
See also
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drug
- Analgesics
- Antipyretics
- Pyrazolones
- Drugs